Atlas Trials

Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

Clinical trial NCT02240381 · TERMINATED

Trial details

NCT number
NCT02240381
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes MellitusMalignant Neoplasm
Start date
2014-11-20
Primary completion
2019-01-08
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.